Purazine Revenue

Biotechnology Research • Melbourne, Victoria, Australia • 1-10 Employees

Purazine revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$547,552
Total funding	No funding

Key Contact at Purazine

Matt Browne

Director

Company overview

Headquarters	Melbourne, Victoria, Australia
Website	purazine.com
Employees	1-10

About Purazine

Purazine™ is a new offering for unprecedented times. Based in Victoria, Australia Purazine™ is the authorised distributor of Nanocyn® Disinfectant & Sanitiser. Nanocyn® has been a global market-leading manufacturer of disinfectants and sanitiser products for nearly 20 years. Nanocyn® together with Purazine’s DRY VAPOUR delivery technology will enable your business to meet the challenge of our unprecedented times – include killing COVID-19 virus. Purazine’s goal is to make Nanocyn® and our Dry Vapour technology available to all workplaces, cafes, restaurants, schools, hospitals or more in order to create a safe and more secure environment.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

Purazine has never raised funding before.

Frequently asked questions

Purazine is located in Melbourne, Victoria, AU.

Purazine generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.

Purazine has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Purazine has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Purazine

Matt Browne

Director

4.8

40,000 users